{"data":{"type":"feed_item","id":378840,"entity_id":"wefunder:feed_item:378840","attributes":{"canonical_url":"https://wefunder.com/feed/378840","retrieval_urls":{"canonical":"https://wefunder.com/feed/378840","json":"https://wefunder.com/feed/378840.json","markdown":"https://wefunder.com/feed/378840.md","ai_json":"https://wefunder.com/feed/378840.ai.json","ai_text":"https://wefunder.com/feed/378840.ai.txt","changelog_json":"https://wefunder.com/feed/378840.changelog.json","schema":"https://wefunder.com/.well-known/ai-profile-schema.json"},"updated_at":"2026-09-04T15:07:53.826Z","generated_at":"2026-11-02T05:53:13Z","profile_visibility":"public","feed_item":{"id":378840,"entity_id":"wefunder:feed_item:378840","type":"FeedItem::Update","title":"AI and drug development: Axiom live on CNBC! 🎥 | Axiom Biosciences","content_plain":"We recently announced our plan to pursue a primary listing on the Hong Kong Stock Exchange in 2027, with a Nasdaq listing to follow in 2029.","published_at":"2026-09-04T15:07:53.395Z","updated_at":"2026-09-04T15:07:53.826Z","canonical_url":"https://wefunder.com/feed/378840","image_url":"https://wefunder.com/rails/active_storage/blobs/redirect/eyJfcmFpbHMiOnsiZGF0YSI6MjE4OTk2NywicHVyIjoiYmxvYl9pZCJ9fQ==--2131d8e38418da1bd4a9f2c028d0d58db620f305/Axiom%20Biosciences-feed-item-378840-cover-photo--cover_photo.jpg","author":{"name":"Remo Moomiaie","profile_url":"https://wefunder.com/remomoomiaie"},"subject":{"name":"Axiom Biosciences","profile_url":"https://wefunder.com/axiombiosciences"}},"provenance":{"source":"wefunder_public_feed_item","last_verified_at":"2026-09-04T15:07:53Z","claims":{"title":{"source":"feed_item.title","last_verified_at":"2026-09-04T15:07:53Z","as_of":"2026-09-04T15:07:53Z","confidence":"high"},"published_at":{"source":"feed_item.published_at","last_verified_at":"2026-09-04T15:07:53Z","as_of":"2026-09-04T15:07:53Z","confidence":"high"}}}}}}